Results for:(80 found)
Apr 1, 2014 12:57PM on Top StocksBy MSN Money Partner

Sales of the hepatitis C treatment Sovaldi are soaring, and insurance companies could see a double-digit cut to profits as a result.

Mar 5, 2014 11:08AM on Top StocksBy Jim Cramer

From airlines to tobacco to pharma, stocks are seeing rare rallies for no apparent reason.

Feb 4, 2014 4:27PM on Top StocksBy MSN Money Partner

Instead of racing against each other, the companies are banding together to fight diabetes, arthritis and Alzheimer's.

Jan 14, 2014 4:23PM on Top StocksBy StreetAuthority

A revolutionary approach to cancer fighting has the medical community buzzing. Here's how to profit.

Dec 16, 2013 3:01PM on Top StocksBy MSN Money Partner

Companies are having a tough time convincing doctors, patients and insurers to give new treatments a try.

Nov 13, 2013 11:56AM on Top StocksBy InvestorPlace

It's a fool's game to hold these. Get out while you can.

Tags: BMYFBX
Nov 8, 2013 10:34AM on Top StocksBy TheStreet.com Staff

With close to $20 billion in cash on the balance sheet, Merck is one key acquisition away from turning its fortunes around.

Nov 1, 2013 9:18AM on Top StocksBy TheStreet.com Staff

JNJ's strong dividend yield of 2.9 percent and its attractive balance means investors won't die in waiting room.

VIDEO ON MSN MONEY

DATA PROVIDERS

Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.

TOP STOCKS

Goldman loses its grip on stock-trading lead

The company is scrambling to protect its equities arm, which could face declining volume and revenue as competitors close the gap.

More

MARKET DISPATCHES

No more Dispatches; here's where to find market news

The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.

More